Faslodex
Active substance: fulvestrant
fulvestrant
Centralised EU authorisationActive
Marketing holder: AstraZeneca AB
Verified 2026-10-09 · EMA
Analogues in other countries- Source: EMA
- Countries with the substance registered: 3
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 19 |
|
| US 24 |
|
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-354f-79bf-97a7-d7fa3e26786c,01a120c3-35cc-72b6-8eec-367c5f15c8b8,01a120c3-3927-7d8b-923d-fef94553d301,01a120c3-3995-7450-bb4c-252112221fd5,01a120c3-3f8d-74e4-979a-0423548113c2;count=19 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-56b0-7660-98af-d4f72aa720cf,01a1208c-a099-7604-8c95-a4d9a5d83469,01a1208c-b427-78b8-bf17-edd83d18f851,01a1208d-b65f-7077-bbe3-7994f3313662,01a1208e-e41b-7409-9b78-66829912dbb3;count=24 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- EMEA/H/C/000540
- Registration status
- Active
- ATC code
- L02BA03
- product · EMA · EMEA/H/C/000540 · Verified 2026-10-09
- registration_status · EMA · EMEA/H/C/000540 · Verified 2026-10-09
- ingredients.0 · EMA · EMEA/H/C/000540 · Verified 2026-10-09